Therefore, KRAS codon 12 mutations in ctDNA represent an important potential biomarker of pancreatic cancer, which is fatal disease that is often diagnosed at advanced stages due to a lack of suitable techniques for early detection and diagnosis22,34. This evidence concerns the gene KRAS and pancreatic neoplasm.